http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101957420-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate | 2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101957420-B1 |
titleOfInvention | Targeting compound of cancer and use thereof |
abstract | More particularly, the present invention relates to a dual contrast agent, a composition for diagnosing cancer, and a method for providing information for monitoring cancer. When the cancer screening compound according to the present invention is administered to an organ or tissue in vivo, the compound can be taken into cancer tissue to simultaneously acquire a radiological image and a fluorescence image, and these are provided as images for cancer diagnosis, And can be used for diagnosis and treatment of cancer using molecular imaging techniques. |
priorityDate | 2017-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 203.